Cargando…

1120. Descriptive Analysis of Monoclonal Antibody Administration for Pregnant Patients with SARS-CoV-2 Infection

BACKGROUND: We studied the safety and efficacy of the use of monoclonal antibodies (MAB) against SARS-CoV-2 in pregnant women who developed COVID-19 infection. METHODS: We conducted a cross-sectional descriptive multi-center study of pregnant patients who developed SARS-CoV-2 infection from January...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vikraman, Praveen Kumar, Chang, Kai Ming, Doan, Thien-Ly, Donaghy, Henry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751764/ http://dx.doi.org/10.1093/ofid/ofac492.959

Ejemplares similares

103. Evaluating The Appropriateness of Vaccine Administration in Patients with Splenectomy
por: Barsoum, Barbara, et al.
Publicado: (2022)

1526. Oral Fosfomycin Use for Urinary Tract Infections and Its Clinical Impact on Hospital Stay
por: Mai, Christina, et al.
Publicado: (2018)

657. Evaluating Clinical Outcomes of Bacteremic Patients Treated with AmpC-Inducing Versus -Stable Agents
por: Barsoum, Barbara, et al.
Publicado: (2022)

2294. Comparative Evaluation of Ertapenem and Clindamycin Plus Gentamicin for the Treatment of Postpartum Endometritis
por: Schweiger, Krislyn, et al.
Publicado: (2019)

1617. Assessment of Bloodstream Infections in Patients with Intrapartum Fever
por: Kamel, Barbara, et al.
Publicado: (2023)

341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab
por: Barsoum, Barbara, et al.
Publicado: (2021)

96. Assessing the Impact of the Meningitis/encephalitis Diagnostic Panel on Antimicrobial Stewardship
por: Garellek, Jonathan, et al.
Publicado: (2020)

Efficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivo
por: Xue, Cong, et al.
Publicado: (2016)

1120. Reliability of Parent-Reported Pediatric Antibiotic Use in a Longitudinal Birth Cohort
por: D’Arinzo, Lauren, et al.
Publicado: (2019)

Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19
por: Zimilover, Adam, et al.
Publicado: (2022)

1120. Impact of Training Residents to Improve HIV Screening in a Teaching Hospital in Mexico City
por: Guerrero-Torres, Lorena, et al.
Publicado: (2020)

Abstract: 11.20 The Potential Of Adipose Derived Stem Cells For Chronic Wounds
por: Rafik, Amine, et al.
Publicado: (2017)

1120. Absorption, Metabolism, and Excretion of [(14)C]-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects
por: Gupta, Vipul K, et al.
Publicado: (2021)

Nintedanib (BIBF 1120) for IPF: a tomorrow therapy?
por: Antoniu, Sabina A
Publicado: (2012)

554. Clinical Impact of Monoclonal Antibody Therapy with SARS-CoV-2 Infection
por: Mann, Inderjit, et al.
Publicado: (2021)

1120 The Impact of Influenza Vaccination in Patients with Cancer on Subsequent Disease during the 2013-2014 Influenza Season
por: Azzi, Jacques, et al.
Publicado: (2014)

1120. Clostridium difficile Infection Risk Factors, Severity, and Outcomes in Patients Infected with NAP1/027 Strain in a Non-Epidemic Setting
por: Nahar, Julie
Publicado: (2018)

530. Bamlanivimab (BAM) for SARS-CoV-2 Infection: Rates and Risk Factors for Hospitalization after Monoclonal Antibody Administration in a High-Risk Population
por: Curtin, John M, et al.
Publicado: (2021)

Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization
por: Anderson, Timothy S., et al.
Publicado: (2022)

Assessing the Risk of Nephrotoxicity Associated With Non-renally Adjusted Intravenous Polymyxin B Compared with Traditional Dosing
por: Maniara, Bejoy, et al.
Publicado: (2017)

1431. Evaluation of Drug-induced Liver Injury in Patients Receiving Anti-tuberculosis Medications and Subsequent Management
por: Acosta, Carina, et al.
Publicado: (2022)

1568. Evaluating the Appropriateness of Antiretroviral Therapy in the Critical Care Setting
por: Wali, Toobah, et al.
Publicado: (2023)

536. Development of post acute sequelae of SARS-Cov-2 infection (long Covid) in outpatient receiving monoclonal antibodies
por: Neto, Amelia, et al.
Publicado: (2023)

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration
por: Follmann, Dean, et al.
Publicado: (2023)

P1120: THE EFFICACY AND SAFETY OF ZANUBRUTINIB AND DEXAMETHASONE IN SYMPTOMATIC WALDENSTROM MACROGLOBULINNEMIA
por: Liu, A., et al.
Publicado: (2022)

513. Use of Antimicrobial Stewardship Program in Operationalizing Monoclonal Antibody Therapy in SARS-CoV-2 Infection
por: Abrantes-Figueiredo, Jessica, et al.
Publicado: (2021)

479. Real-world Evaluation of SARS-CoV-2 Monoclonal Antibodies in Solid Organ Transplant Recipients
por: Zeitler, Kristen, et al.
Publicado: (2021)

280. Monoclonal Antibodies Against SARS-CoV-2 in Fragile Outpatients: Clinical and Laboratory Risk Factors and Protective Role of Vaccination
por: Cavasio, Rosario Alessandro, et al.
Publicado: (2022)

1348. Identification of GB-0669, a Novel S-2 Targeted Spike Monoclonal Antibody in Development for SARS-CoV-2 Prophylaxis
por: Borriello, Francesco, et al.
Publicado: (2023)

Abstract: 11.20 Prior Radiotherapy Does Not Affect Abdominal Wall Reconstruction Nor Ventral Hernia Repair Outcomes
por: Giordano, Salvatore, et al.
Publicado: (2017)

360. A First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies
por: Asiago, Josephat, et al.
Publicado: (2023)

882. Evaluating the Risk Factors in Postoperative Infections Following Hysterectomy Procedures: Is Antibiotic Prophylaxis the Issue?
por: Yi, Stacie, et al.
Publicado: (2020)

205. Evaluating the Time to Oral Step-Down Therapy for Gram-Negative Bloodstream Infections Associated with a Genitourinary Source
por: Mulvey, Nicole, et al.
Publicado: (2021)

489. SARS-CoV-2 Seroprevalence and Antibody Response Among Pregnant People in Seattle, WA
por: LaCourse, Sylvia, et al.
Publicado: (2021)

514. Anti-SARS-CoV-2 Monoclonal Antibodies for Early COVID-19: A Real World Experience
por: Belden, Katherine, et al.
Publicado: (2021)

532. Establishing a SARS-CoV-2 Monoclonal Antibody Infusion Clinic: Early Trends in Outcomes and Disparities
por: Hare, Allison J, et al.
Publicado: (2021)

Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2022)

1958. Longitudinal SARS-COV-2 anti-spike antibody response in pregnant people with natural infection and variable vaccine uptake
por: LaCourse, Sylvia M, et al.
Publicado: (2022)

New 11,20-Epoxybriaranes from the Gorgonian Coral Junceella fragilis (Ellisellidae)
por: Lin, Chia-Cheng, et al.
Publicado: (2019)

Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
por: Halwe, Sandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_89gc0srvr23an0pec0k8eglkvs